Begin typing your search above and press return to search.
Maharashtra Tested Skin-Disease Drug For COVID-19 Patients
By: Tupaki Desk | 4 May 2020 9:20 AM GMT
The novel coronavirus originated from the Wuhan province of China is spreading its deadly wings in India as the positive cases in the country have surpassed the 42,000 mark raising many fears and concerns.
Maharashtra continues to be the worst-hit state in India due to the COVID-19 outbreak as it is the first-ever state in India to report more than 12,000. The safety measures taken by the state government went in vain.
The BYL Nair Hospital, the biggest COVID-19 hospital in Mumbai has tested the 'Itolizumab' drug for the critical patients of COVID-19 and the doctors claimed that their situation became normal.
Brihanmumbai Municipal Corporation(BMC) Chairperson Kiran Majumdar Shaw said that the drug which will cost around Rs 60,000 will be given for free in all the hospitals run by the corporation.
On the other hand, the King Edward memorial hospital in Mumbai has tried this drug on a 35-year COVID-19 patient and planning to provide this drug to 125 more patients reportedly.
Maharashtra continues to be the worst-hit state in India due to the COVID-19 outbreak as it is the first-ever state in India to report more than 12,000. The safety measures taken by the state government went in vain.
The BYL Nair Hospital, the biggest COVID-19 hospital in Mumbai has tested the 'Itolizumab' drug for the critical patients of COVID-19 and the doctors claimed that their situation became normal.
Brihanmumbai Municipal Corporation(BMC) Chairperson Kiran Majumdar Shaw said that the drug which will cost around Rs 60,000 will be given for free in all the hospitals run by the corporation.
On the other hand, the King Edward memorial hospital in Mumbai has tried this drug on a 35-year COVID-19 patient and planning to provide this drug to 125 more patients reportedly.
